A Mixture of Phenolic Metabolites of Quercetin Can Decrease Elevated Blood Pressure of Spontaneously Hypertensive Rats Even in Low Doses
Language English Country Switzerland Media electronic
Document type Journal Article
Grant support
17-05409S
Grantová Agentura České Republiky
CZ.02.1.01/0.0/0.0/16_019/0000841
The ministry of education, youth and sport (CZ)
PubMed
31947563
PubMed Central
PMC7019299
DOI
10.3390/nu12010213
PII: nu12010213
Knihovny.cz E-resources
- Keywords
- blood pressure, in vivo, infusion, phenolic, quercetin, rat,
- MeSH
- Antihypertensive Agents pharmacokinetics MeSH
- Biological Availability MeSH
- Phenols pharmacokinetics MeSH
- Hypertension drug therapy MeSH
- Catechols pharmacokinetics MeSH
- Blood Pressure drug effects MeSH
- Rats MeSH
- 3,4-Dihydroxyphenylacetic Acid pharmacokinetics MeSH
- Coumaric Acids pharmacokinetics MeSH
- Disease Models, Animal MeSH
- Rats, Inbred SHR MeSH
- Quercetin chemistry MeSH
- Dose-Response Relationship, Drug MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- 4-methylcatechol MeSH Browser
- Antihypertensive Agents MeSH
- dihydro-3-coumaric acid MeSH Browser
- Phenols MeSH
- Catechols MeSH
- 3,4-Dihydroxyphenylacetic Acid MeSH
- Coumaric Acids MeSH
- Quercetin MeSH
Quercetin is proven to decrease arterial blood pressure when given orally. Its bioavailability is, however, low and, therefore, its metabolites could rather be responsible for this effect. In particular, the colonic metabolites of quercetin, 3,4-dihydroxyphenylacetic acid (DHPA), 4-methylcatechol (4MC), and 3-(3-hydroxyphenyl)propionic acid (3HPPA), have been previously shown to decrease the blood pressure in spontaneously hypertensive rats (SHR). Interestingly, the mechanisms of action of these three metabolites are different. The aim of this study is hence to investigate if these metabolites can potentiate each other and thus decrease blood pressure in reduced doses. Three double-combinations of previously mentioned metabolites were administered to SHR as infusions to mimic a real biological situation. All combinations significantly decreased the blood pressure in SHR but there were important differences. The effect of DHPA and 4MC was mild and very short. A combination of DHPA with 3HPPA caused more pronounced effects, which were also rather short-lived. The last combination of 3HPPA and 4MC caused a long-lasting effect. In conclusion, certain combinations of quercetin metabolites have a more pronounced antihypertensive effect than single metabolites.
See more in PubMed
Perez A., Gonzalez-Manzano S., Jimenez R., Perez-Abud R., Haro J.M., Osuna A., Santos-Buelga C., Duarte J., Perez-Vizcaino F. The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: Correlation with beta-glucuronidase activity. Pharmacol. Res. 2014;89:11–18. doi: 10.1016/j.phrs.2014.07.005. PubMed DOI
Edwards R.L., Lyon T., Litwin S.E., Rabovsky A., Symons J.D., Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J. Nutr. 2007;137:2405–2411. doi: 10.1093/jn/137.11.2405. PubMed DOI
Williamson G., Kay C.D., Crozier A. The Bioavailability, Transport, and Bioactivity of Dietary Flavonoids: A Review from a Historical Perspective. Compr. Rev. Food Sci. Food Saf. 2018;17:1054–1112. doi: 10.1111/1541-4337.12351. PubMed DOI
Rechner A.R., Smith M.A., Kuhnle G., Gibson G.R., Debnam E.S., Srai S.K., Moore K.P., Rice-Evans C.A. Colonic metabolism of dietary polyphenols: Influence of structure on microbial fermentation products. Free Radic. Biol. Med. 2004;36:212–225. doi: 10.1016/j.freeradbiomed.2003.09.022. PubMed DOI
De Bruyne T., Steenput B., Roth L., De Meyer G.R.Y., Santos C.N.D., Valentova K., Dambrova M., Hermans N. Dietary Polyphenols Targeting Arterial Stiffness: Interplay of Contributing Mechanisms and Gut Microbiome-Related Metabolism. Nutrients. 2019;11:578. doi: 10.3390/nu11030578. PubMed DOI PMC
Galindo P., Rodriguez-Gomez I., Gonzalez-Manzano S., Duenas M., Jimenez R., Menendez C., Vargas F., Tamargo J., Santos-Buelga C., Perez-Vizcaino F., et al. Glucuronidated quercetin lowers blood pressure in spontaneously hypertensive rats via deconjugation. PLoS ONE. 2012;7:e32673. doi: 10.1371/journal.pone.0032673. PubMed DOI PMC
Najmanova I., Pourova J., Voprsalova M., Pilarova V., Semecky V., Novakova L., Mladenka P. Flavonoid metabolite 3-(3-hydroxyphenyl) propionic acid formed by human microflora decreases arterial blood pressure in rats. Mol. Nutr. Food Res. 2016;60:981–991. doi: 10.1002/mnfr.201500761. PubMed DOI
Pourova J., Najmanova I., Voprsalova M., Migkos T., Pilarova V., Applova L., Novakova L., Mladenka P. Two flavonoid metabolites, 3,4-dihydroxyphenylacetic acid and 4-methylcatechol, relax arteries ex vivo and decrease blood pressure in vivo. Vasc. Pharmacol. 2018;111:36–43. doi: 10.1016/j.vph.2018.08.008. PubMed DOI
Feliciano R.P., Boeres A., Massacessi L., Istas G., Ventura M.R., Nunes Dos Santos C., Heiss C., Rodriguez-Mateos A. Identification and quantification of novel cranberry-derived plasma and urinary (poly) phenols. Arch. Biochem. Biophys. 2016;599:31–41. doi: 10.1016/j.abb.2016.01.014. PubMed DOI
Margalef M., Iglesias-Carres L., Pons Z., Bravo F.I., Muguerza B., Arola-Arnal A. Age related differences in the plasma kinetics of flavanols in rats. J. Nutr. Biochem. 2016;29:90–96. doi: 10.1016/j.jnutbio.2015.11.007. PubMed DOI
Margalef M., Pons Z., Iglesias-Carres L., Bravo F.I., Muguerza B., Arola-Arnal A. Flavanol plasma bioavailability is affected by metabolic syndrome in rats. Food Chem. 2017;231:287–294. doi: 10.1016/j.foodchem.2017.03.141. PubMed DOI
Conterno L., Martinelli F., Tamburini M., Fava F., Mancini A., Sordo M., Pindo M., Martens S., Masuero D., Vrhovsek U., et al. Measuring the impact of olive pomace enriched biscuits on the gut microbiota and its metabolic activity in mildly hypercholesterolaemic subjects. Eur. J. Nutr. 2019;58:63–81. doi: 10.1007/s00394-017-1572-2. PubMed DOI PMC
Applova L., Karlickova J., Warncke P., Macakova K., Hrubsa M., Machacek M., Tvrdy V., Fischer D., Mladenka P. 4-Methylcatechol, a Flavonoid Metabolite with Potent Antiplatelet Effects. Mol. Nutr. Food Res. 2019;63:e1900261. doi: 10.1002/mnfr.201900261. PubMed DOI
Oudot C., Gomes A., Nicolas V., Le Gall M., Chaffey P., Broussard C., Calamita G., Mastrodonato M., Gena P., Perfettini J.L., et al. CSRP3 mediates polyphenols-induced cardioprotection in hypertension. J. Nutr. Biochem. 2019;66:29–42. doi: 10.1016/j.jnutbio.2019.01.001. PubMed DOI